Immunostimulatory sequences of DNA and conjugates in the treatment of allergic rhinitis
Tóm tắt
Therapeutic strategies based on the use of Immunostimulatory sequences of DNA containing a CpG motif (also known as ISS DNA, or CpG DNA) are focused on minimizing the allergenicity of immunotherapy while improving its effectiveness. Several ISS DNA-based methods of immunization (ISS DNA alone, ISS DNA conjugated to a protein allergen) have shown promise in animal models of asthma, and some of these ISS DNA-based therapies have entered clinical trials. These ongoing clinical trials will help to determine whether any of these ISS DNA-based therapies are safe and effective to use in subjects with allergic rhinitis and asthma.
Tài liệu tham khảo
Yamamoto S, Yamamoto T, Kataoka T, et al.: Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer cell activity. J Immunol 1992, 148:4072–4076.
Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20:709–760.
Spiegelberg HL, Horner AA, Takabayashi K, Raz E: AllergenImmunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy. Curr Opin Allergy Clin Immunol 2002, 2:547–551.
Hayashi T, Beck L, Rossetto C, et al.: Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004, 114:270–279.
Kline JN, Krieg AM, Waldschmidt TJ, et al.: CpG oligodeoxynucleotides do not require Th1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999, 104:1258–1264.
Broide D, Schwarze J, Tighe H, et al.: Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998, 161:7054–7062.
Ikeda RK, Nayar J, Cho JY, et al.: Resolution of gnairway inflammation following OVA inhalation: comparison of ISS DNA and corticosteroids. Am J Resp Cell Mol Biol 2003, 28:655–663.
Cho J, Miller M, Baek K, et al.: Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J Allergy Clin Immunol 2001, 108:697–702.
Cho JY, Miller M, Baek KJ, et al.: Immunostimulatory DNA inhibits TGF-beta expression and airway remodeling. Am J Resp Cell Mol Biol 2004, 30:651–661.
Cho JY, Miller M, Baek KJ, et al.: Immunostimulatory DNA reverses established allergen induced airway remodeling. J Immunol 2004, 30:7556–7664. This study demonstrates that ISS can reverse established airway remodeling in mice.
Cho JY, Miller M, Baek KJ, et al.: Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004, 113:551–560.
Flood-Page P, Menzies-Gow A, Phipps S, et al.: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003, 112:1029–1036.
Fanucchi MV, Schelegle ES, Baker GL, et al.: Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am J Respir Crit Care Med 2004, 170:1153–1157.
Bohle B, Jahn-Schmid B, Maurer D, et al.: Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18, and IFN-gamma production in cells from allergic individuals and inhibits IgE synthesis in vitro. Eur J Immunol 1999, 29:2344–2353.
Shirota H, Sano K, Hirasawa K, et al.: Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG tagged antigen by dendritic cells. J Immunol 2001, 167:66–74.
Tighe H, Takabayashi K, Schwartz D, et al.: Conjugation of Immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000, 106:124–134.
Santeliz JV, Van Nest G, Traquina P, et al.: Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002, 109:455–462.
Marshall JD, Abtahi S, Eiden J, et al.: Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes Th1 cytokine expression while downregulating Th2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001, 108:191–197.
Simons FE, Shikishima Y, Van Nest G, et al.: Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to Immunostimulatory DNA. J Allergy Clin Immunol 2004, 113:1144–1151.
Creticos PS, Eiden JJ, Balcer SL, et al.: Immunostimulatory oligodeoxynucleotides conjugated to Amb a 1: safety, skin test reactivity, and basophil histamine release. J Allergy Clin Immunol 2000, 105:S70.
Creticos PS, Eiden JJ, Broide DH, et al.: Immunotherapy with Immunostimulatory oligonucleotides linked to purified ragweed Amb a 1 allergen: effects on antibody production, nasal allergen provocation, and ragweed seasonal rhinitis. J Allergy Clin Immunol 2002, 109:743.
Tulic MK, Fiset PO, Christodoulopoulos P, et al.: Amb a 1-Immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004, 13:235–241. This study demonstrates that AIC inhibits Th2 responses in the nasal mucosa of human subjects with allergic rhinitis.